In2Pharma
  • Home
  • Services
    • Regulatory Affairs
    • Quality Assurance
    • Publicity and Compliance
    • Medical writing & training
    • Vigilance
  • About Us
  • News
  • Contact
Select Page
Updated Adverse Drug Reaction Reporting Details for Belgium

Updated Adverse Drug Reaction Reporting Details for Belgium

by In2Pharma | Mar 10, 2021 | News

Europe Appendix V of the QRD template has been updated. This appendix lists the details of the national reporting systems for communicating adverse reactions, which must be stated in the SmPC and the package leaflet. In the most recently updated versions of...

Recent Posts

  • Introduction to FAMHP portal – manufacturing inspections
  • RD export 19/01/2023 – mandatory application for export
  • Fiscal importation of medicines from 3rd countries
  • NARCOTIC/PSYCHOTROPIC LEGISLATION: important clarifications concerning the narcotic order forms
  • Negative formulations no longer allowed on packaging of medicinal products for human use

Follow Us

  • Facebook
  • LinkedIn
Privacy Policy | Cookie Policy | BTW BE 895730662 | +32 16 89 16 00| info@in2pharma.com | Terloonststraat 22, 1910 Kampenhout, België